ArticleSocial psychiatry and psychiatric epidemiology2013
Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.
Article in Social psychiatry and psychiatric epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data.European journal of clinical pharmacology · 2019Pooled it
- The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China.BMC psychiatry · 2025Article
- Trends and off-label utilization of antipsychotics in children and adolescents from 2016 to 2021 in China: a real-world study.Child and adolescent psychiatry and mental health · 2024Article
- Cardiovascular and metabolic risk of antipsychotics in children and young adults: a multinational self-controlled case series study.Epidemiology and psychiatric sciences · 2021Article
- Comparative cardiometabolic risk of antipsychotics in children, adolescents and young adults.European child & adolescent psychiatry · 2021Article
- Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.European child & adolescent psychiatry · 2018Article
- Influence of socioeconomic status on antipsychotic prescriptions among youth in France.BMC psychiatry · 2017Article
- Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.European child & adolescent psychiatry · 2015Article
- Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study.Neuropsychiatric disease and treatment · 2015Article
- Dental utilization and expenditures by children and adolescents with autism spectrum disorders: A population-based cohort study.Tzu chi medical journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe used Taiwan's population-based National Health Insurance database to investigate the trends, correlates, and disease patterns of antipsychotic use among children and adolescents.
methodsThe National Health Research Institutes provided a database of 1,000,000 random subjects for study. We chose subjects who were aged 18 years or younger during 1997-2005. In this sample, subjects who were given at least one antipsychotic prescription, including first-generation antipsychotics (FGAs) or second-generation antipsychotics (SGAs), were identified. Trends, prevalence, and associated factors of antipsychotic use were determined. The proportion of antipsychotic use for psychiatric and medical disorders was also analyzed.
resultsThe 1-year prevalence of SGA use increased from 0.00 % in 1997 to 0.09 % in 2005, whereas the 1-year prevalence of FGA use ranged from 2.24 to 3.43 % during this same period, with no significant change. Age and male gender were associated with higher SGA use. Among SGA users, the greatest proportion suffered from psychiatric disorders, including tics, hyperkinetic syndrome of childhood, schizophrenia, affective disorders, and autism. Among FGA users, a larger proportion was for medical conditions, including diseases of the digestive and respiratory systems.
conclusionThe prevalence of pediatric SGA use increased greatly from 1997 to 2005. Among pediatric subjects using antipsychotics, SGAs were mostly used for psychiatric disorders, whereas FGAs were mostly prescribed for medical conditions. Future research will focus on indication, dosage, frequency, duration, adverse effects, and off-label use of antipsychotics in the pediatric population.
Indexed as
Identifiers
23653092What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.